Revisiting dietary antioxidants, neurodegeneration and dementia

NeuroReport

Volumn 22, Issue 1, 2011, Pages 1-3

  Craggs, Lucinda ^a   Kalaria, Raj N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antioxidants; Curcumin; Dementia; Neurodegeneration; Vascular

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CURCUMIN; FLAVONOID; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RESVERATROL; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL (TOPIC); DEMENTIA; DIETARY INTAKE; FRUIT; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPICE; VEGETABLE; VITAMIN INTAKE;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; DEMENTIA; DIET; HUMANS; NERVE DEGENERATION;

EID: 79551538975     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328342741c     Document Type: Article

References (26)

1. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 2008; 15:473-479.
2. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006; 65:631-641.
3. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287:3230-3237.
4. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287:3223-3229.
5. Luchsinger JA, Tang M-X, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003; 60:203-208.
6. Laurin D, Masaki KH, Foley DJ,White LR, Launer LJ. Midlife dietary intake of antioxidants and risk of late-life incident dementia. Am J Epidemiol 2004; 159:959-967.
7. Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the cache county study. Arch Neurol 2004; 61:82-88.
8. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59:912-921. (Pubitemid 43830923)
9. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. Fruit and vegetable juices and Alzheimer's disease: The KAME Project. Am J Med 2006; 119:751-759.
10. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000; 16:357-363.
11. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, et al. Phenolic anti-inflammatory antioxidant reversal of A[beta]-induced cognitive deficits and neuropathology. Neurobiol Aging 2001; 22:993-1005.
12. Zhao B, Li X, He R, Cheng S, Wenjuan X. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biochem Biophy 1989; 14:175-185.
13. Bisht K, Wagner K-H, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 2010; 278:88-100.
14. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21:8370-8377.
15. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, et al. Curcumin inhibits formation of amyloid Î2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005; 280:5892-5901.
16. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Therap 2008; 326:196-208.
17. Kim SJ, Son TG, Park HR, Park M, Kim M-S, Kim HS, et al. Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 2008; 283:14497-14505.
18. Mishra S, Mishra M, Seth P, Sharma SK. Tetrahydrocurcumin confers protection against amyloid β-induced toxicity. NeuroReport 2011; 22:23-27.
19. Morihara T, Yang F, Lim G, Teter B, Ambegaokar S, Beech W, et al. P4-337 Regulation of microglial activation and effects of abeta production by ibuprofen and curcumin, an anti-inflammatory and anti-oxidative compound that suppresses amyloid in TG2576 (APPSW mice). Neurobiol Aging 2004; 25:S571.
20. Kwok-Kuen Cheung S, Shuk-Wai Ho A, Lawrence L, Baum W. Curcumin decreases tau pathology and mortality in transgenic mouse models of Alzheimer's disease. Alzheimers Demen 2010; 6:S553.
21. Sung S, Yao Y, Uryu K, Yang H, Lee VMY, Trojanowski JQ, et al. Early vitamin E supplementation in young but not aged mice reduces A levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J 2004; 18:323-325.
22. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, et al. Moderate consumption of Cabernet Sauvignon attenuates a neuropathology in a mouse model of Alzheimer's disease. FASEB J 2006; 20:2313-2320.
23. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, et al. Grape-derived polyphenolics prevent A oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 2008; 28:6388-6392.
24. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005; 25:8807-8814.
25. Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009; 1282:133-141.
26. Baum L, Lam CWK, Cheung SK-K, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. -J Clin Psychopharmacol 2008; 28:110-113.